Neonatal severe intractable diarrhoea as the presenting manifestation of an unclassified congenital disorder of glycosylation (CDG-x)

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 85, Issue 3, 2001, Pages

  Mention, K ^a   Michaud, L ^a   Dobbelaere, D ^b   Guimber, D ^a   Gottrand, F ^a   Turck, D ^a,c  

^a UNIV LILLE   (France)

^b Department of Paediatrics

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Diarrhoea; Hepatic insufficiency; Neurological impairment; Protein losing enteropathy

Indexed keywords

CASE REPORT; CONGENITAL DISORDER OF GLYCOSYLATION; DISEASE COURSE; FATALITY; HUMAN; INFANTILE DIARRHEA; ISOELECTRIC FOCUSING; LIVER FAILURE; MALE; NEUROLOGIC DISEASE; NEWBORN; REVIEW; TOTAL PARENTERAL NUTRITION;

CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME; DIARRHEA, INFANTILE; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; INFANT, NEWBORN; ISOELECTRIC FOCUSING; LIVER FAILURE; MALE; NERVOUS SYSTEM DISEASES; PARENTERAL NUTRITION, TOTAL;

EID: 0035512715     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.85.3.f217     Document Type: Article

References (12)

1. Jaeken J, Vanderbchueren-Lodeweyckx M, Casaer P, et al. Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG deficiency, increased serum arylsulfatase A and increased CSF protein: a new syndrome' [Abstract] Pediatr Res 1980;14:179
2. Leonard J, Grünewald S, Clayton P. Diversity of congenital disorders of glycosylation. Lancet 2001;357;1382-3.
3. de Lonlay P, Seta N, Barrot S, et al. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet 2001;38-14-9.
4. Erlandson A, Bjursell C, Stibler H, et al. Scandinavian CDG-Ia patients genotype/phenotype correlation and geographic origin of founder mutations Hum Genet 2001;108:359-67.
5. Jaeken J, Matthijs G, Saudubray JM, et al Phosphomannose isomerase deficiency a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet 1998;62:1535-9.
6. Niehues R, Hasilik M, Alton G, et al. Carbohydrate-deficient glycoprotein syndrome type 1b. Phosphoman-nose isomerase deficiency and mannose therapy J Clin Invest 1998;101:1414-20.
7. Kristiansson B, Borulf S, Conradi N, et al Intestinal, pancreatic and hepatic involvement in carbohydrate-deficient glycoprotein syndrome type 1. J Pediatr Gastroenterol Nutr 1998;27:23-9.
8. Conradi N, De Vos R, Jaeken J, et al. Liver pathology in the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand Suppl 1991;375:50-4
9. Kjaergaard S, Kristiansson B, Stibler H, et al. Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type IA. Acta Paediatr 1998;87:884-8.
10. Acarregui MJ, George TN, Rhead WJ, Carbohydrate-deficient glycoprotein syndrome type I with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities. J Pediatr 1998;133:697-700.
11. Guarino A, Spagnuolo MI, Russo S, et al. Etiology and risk factors of severe and protracted diarrhea. J Pediatr Gastroenterol Nutr 1995;20:173-8.
12. Catassi C, Fabiani E, Spagnuolo MI, et al. Severe and protracted diarrhea: results of the 3-year SIGEP multicenter survey. Working Group of the Italian Society of Pediatric Gastroenterology and Hepatology (SIGEP). J Pediatr Gastroenterol Nutr 1999;29:63-8.